[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"pulmonary-aspiration-during-anaesthetic-induction\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:pulmonary-aspiration-during-anaesthetic-induction":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,48,88],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":22,"studyType":23,"phases":4,"briefSummary":24,"conditions":25,"keywords":29,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":37,"lastUpdatePostDateStruct":38,"startDateStruct":41,"completionDateStruct":42,"leadSponsor":44,"locationsCount":47},"100631874","investigation-of-gastric-emptying-by-gastric-ultrasonography-in-diabetic-patients-treated-with-glp-1-receptors-100631874",false,"NCT07506356","Investigation of Gastric Emptying by Gastric Ultrasonography in Diabetic Patients Treated With GLP-1 Receptors","Investigation of Gastric Emptying by Gastric Ultrasonography in Diabetic Patients Treated With GLP-1 Receptors Agonists","SAGUSE","Inclusion Criteria:\n\n* Female\u002F Male of 18 years old or more\n* With Type 2 Diabetes\n* Treated with GLP 1 analog for more than 3 months\n* Signed consent\n* ASA between I and IV\n\nExclusion Criteria:\n\n* Insuline treatment\n* Gastro intestinal motility disorders\n* Past gastric surgery\n* Hiatal hernia\n* Recent trauma\n* Inability to be lay down for the exam\n* Inability to follow the instructions for the exam (language, dementia)\n* BMI \\> 40\n* Inability to stop smoking 12h before the measures","ALL","18 Years",{"count":20,"type":21},38,"ESTIMATED","7 Days","OBSERVATIONAL","Treatment with semaglutide slows down gastric emptying , food remains in the stomach for a longer period of time. This slowing has important implications for anesthesia management. At present, we do not know the optimal duration for discontinuing this medication before surgery and anesthesia to ensure an empty stomach.\n\nThis is an observational research project, conducted exclusively at the Geneva University Hospitals (HUG). To answer the research question, participation of 38 individuals will be required. The duration of participation for each person is 7 days.\n\nTo recruit the necessary number of participants, approximately 1.5 years will be needed.\n\nThis project is being carried out in accordance with Swiss legal requirements and recognized international guidelines. The competent ethics committee has reviewed and approved this project.\n\nThe project will last 7 day during which the participants will need to come 3 times at the hospital to make gastric ultrasounds. On these days the participants will be asked to have a breakfast between 7 and 8 am including a minimum of bread and\u002For cereals and\u002For proteins. After that the participants will be asked to fast for 6 hours for solide food and 2 hours for liquids. If the participants smokes, they must for 12h before the exam.\n\nAt 2Pm an anesthesiologist will welcome the participant to make the exam at the hospital to evaluate the gastric volume after what the participants will be able to get a small collation and go back home.",[26,27,28],"Diabete Type 2","Regurgitation","Pulmonary Aspiration During Anaesthetic Induction",[30,31,32,33,34,35],"GLP-1 agonists","GLP-1 analog","Diabetes","Gastric ultrasound","Anesthesia","GUS","RECRUITING","2026-03-27",{"date":39,"type":40},"2026-04-01","ACTUAL",{"date":39,"type":21},{"date":43,"type":21},"2026-12-31",{"name":45,"class":46},"University Hospital, Geneva","OTHER",1,{"id":49,"slug":50,"hasResults":11,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":54,"eligibilityCriteria":55,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":56,"targetDuration":4,"studyType":58,"phases":59,"briefSummary":61,"conditions":62,"keywords":66,"overallStatus":77,"whyStopped":4,"lastUpdateSubmitDate":78,"lastUpdatePostDateStruct":79,"startDateStruct":81,"completionDateStruct":83,"leadSponsor":85,"locationsCount":87},"100600684","phase-4-gastric-emptying-with-metoclopramide-in-glp-1-agonist-patients-undergoing-elective-surgery-100600684","NCT07100691","Gastric Emptying With Metoclopramide in GLP-1 Agonist Patients Undergoing Elective Surgery","Preoperative Metoclopramide to Enhance Gastric Emptying in Patients on Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss: A Randomised Controlled Trial With Ultrasound Assessment","GEM-GLP1RA","Inclusion Criteria:\n\n* Patients taking GLP-1 receptor agonists (for weight loss only)\n* Male and female patients aged 18 years or older\n* Able to provide written informed consent\n* ASA grade I-V\n* Scheduled for elective surgery with an expected overnight hospital stay\n\nExclusion Criteria:\n\n* Inability to provide informed consent\n* Presence of hiatus hernia\n* History of any gastric surgery\n* Pregnancy\n* Inability to lie in the right lateral decubitus position\n* Patients taking chronic opioids\n* Poorly controlled diabetes (HbA1c \\>69 mmol\u002Fmol)\n* Urgent or emergency surgery, including trauma\n* Diagnosis of Parkinson's disease\n* Allergy or intolerance to metoclopramide",{"count":57,"type":21},80,"INTERVENTIONAL",[60],"PHASE4","This is a multicentre, investigator-blinded, randomised controlled trial evaluating whether the use of oral metoclopramide before surgery can reduce the amount of residual gastric content in patients who are taking glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for weight loss. These medications are known to slow down gastric emptying, which may increase the risk of pulmonary aspiration during anaesthesia. Patients will be randomly assigned to either receive metoclopramide 24 hours before surgery or continue with standard care. The primary outcome will be the presence or absence of residual gastric content on ultrasound before surgery. Secondary outcomes include nausea, vomiting, constipation, and any adverse effects of the medication.",[28,63,64,65],"Gastric Emptying Time","Preoperative Risk Assessment","Obesity (Disorder)",[67,68,69,70,71,72,73,74,75,76],"GLP-1 Receptor Agonist","Metoclopramide","Elective Surgery","Residual Gastric Content","Gastric Ultrasound","Aspiration Risk","Perioperative Management","Obesity Medications","Randomised Controlled Trial","Anaesthesia Safety","NOT_YET_RECRUITING","2025-08-01",{"date":80,"type":40},"2025-08-06",{"date":82,"type":21},"2025-08",{"date":84,"type":21},"2026-06",{"name":86,"class":46},"Mater Misericordiae University Hospital",2,{"id":89,"slug":90,"hasResults":11,"nctId":91,"briefTitle":92,"officialTitle":93,"acronym":94,"eligibilityCriteria":95,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":96,"targetDuration":4,"studyType":23,"phases":4,"briefSummary":98,"conditions":99,"keywords":100,"overallStatus":77,"whyStopped":4,"lastUpdateSubmitDate":103,"lastUpdatePostDateStruct":104,"startDateStruct":106,"completionDateStruct":108,"leadSponsor":109,"locationsCount":4},"100566744","effects-of-beginning-a-glp1-agonist-therapy-on-residual-gastric-content-and-gastric-emptying-100566744","NCT06659159","Effects of Beginning a GLP1-Agonist Therapy on Residual Gastric Content and Gastric Emptying","Effects of Beginning a GLP1-Agonist Therapy on Residual Gastric Content and Gastric Emptying: a Prospective Ultrasound Approach with Focus on Perioperative Aspiration Risk.","GLP-1","Inclusion Criteria:\n\n* Beginning a new treatment with GLP-1 Agonists. Indication and prescription determined by an endocrinologist\u002Fobesity specialist\n* Signed informed consent\n\nExclusion Criteria:\n\n* Known pregnancy, known lactation\n* Underage (\\\u003C 18 years)\n* Absence of informed consent (missing or inability to provide)\n* Anomalies of the gastrointestinal tract\n* Known illnesses of the gastrointestinal tract\n* Previous surgery of the gastrointestinal tract\n* Elevated risk for hypoglycaemia (Sulfonylurea or Insulin)\n* No investigator with completed structural education in gastric sonography is available\n* Lack of intention to respect the fasting intervals and predefined standardised meals for the sonographic examination",{"count":97,"type":21},50,"This project explores the elevated risk of pulmonary aspiration during anesthesia in patients undergoing GLP-1 agonist therapy, which prolongs gastric emptying. Despite standard fasting guidelines (6 hours for solids, 2 hours for liquids), some patients still experience aspiration, indicating that GLP-1 therapy may heighten risk. The American Society of Anesthesiologists has advised pausing GLP-1 therapy before surgery, but this recommendation has faced criticism for being too broad. More data on this issue is needed, particularly concerning the effect of tachyphylaxis (reduced drug response over time) on gastric emptying.\n\nThe study proposes using gastric ultrasound as a non-invasive tool to evaluate residual gastric content and categorize patients by their aspiration risk. The study will assess the stomach's content and gastric emptying time in patients both before and after starting GLP-1 therapy, comparing results under standard fasting conditions.\n\nThe project is a national, single-center, prospective observational study targeting 50 patients, examining factors like patient demographics, GLP-1 therapy details, and gastrointestinal side effects. Data collection will occur through baseline and follow-up sonographic exams before and after therapy initiation. The study aims to improve perioperative management strategies by clarifying the risks associated with GLP-1 therapy",[28],[101,33,94,102],"Pulmonary aspiration","Gastroparesis","2024-10-23",{"date":105,"type":40},"2024-10-26",{"date":107,"type":21},"2024-11-01",{"date":43,"type":21},{"name":110,"class":46},"Sascha Battig"]